Manyahi Joel, Tellevik Marit Gjerde, Ndugulile Faustine, Moyo Sabrina J, Langeland Nina, Blomberg Bjørn
1 Department of Clinical Science, University of Bergen , Bergen, Norway .
2 Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania .
Microb Drug Resist. 2017 Jan;23(1):37-43. doi: 10.1089/mdr.2016.0074. Epub 2016 Aug 17.
Cotrimoxazole is widely used, particularly as a prophylactic drug in HIV patients. We assessed resistance mechanisms among cotrimoxazole resistant-Gram negative bacterial isolates (n = 123) obtained from blood (n = 69) and urine (n = 54) from Tanzanian patients. sul genes were detected in 98% (121/123) of the isolates. Coexistence of sul1 and sul2 was common (49/123). The dfr genes were found in 63% (77/123) of all isolates. sul1, dfrA15, and dfrA5 genes predominated among Klebsiella pneumoniae, while sul2 and dfrA1 genes were frequent in Escherichia coli isolates. Two isolates, both K. pneumoniae, carried sul3. Integrons were detected in 81.3% (100/123) of all isolates. Class 1 integrons were found in 95% (42/44), 53% (23/43), and 80.6% (25/31) of K. pneumoniae, E. coli, and other Enterobacteriaceae isolates, respectively. Class 2 integrons were found in 14% of E. coli, but not in K. pneumoniae. All sul1 genes in K. pneumoniae were carried in class 1 integrons. Gene cassette arrays dfrA5 and dfrA15-aadA1 were most frequently associated with class 1 integrons, while class 2 integrons contained only dfrA1-sat2-aadA1 gene cassettes. This is the first report of sul3 gene in K. pneumoniae from human sources. The finding that mechanisms differ between E. coli and K. pneumoniae may broaden our understanding of cotrimoxazole resistance.
复方新诺明被广泛使用,尤其是作为艾滋病患者的预防用药。我们评估了从坦桑尼亚患者的血液(n = 69)和尿液(n = 54)中分离出的耐复方新诺明革兰氏阴性菌(n = 123)的耐药机制。在98%(121/123)的分离株中检测到sul基因。sul1和sul2共存很常见(49/123)。在所有分离株的63%(77/123)中发现了dfr基因。sul1、dfrA15和dfrA5基因在肺炎克雷伯菌中占主导地位,而sul2和dfrA1基因在大肠杆菌分离株中很常见。有两株分离株均为肺炎克雷伯菌,携带sul3。在所有分离株的81.3%(100/123)中检测到整合子。1类整合子分别在44株肺炎克雷伯菌、43株大肠杆菌和31株其他肠杆菌科分离株中的95%(42/44)、53%(23/43)和80.6%(25/31)中被发现。2类整合子在14%的大肠杆菌中被发现,但在肺炎克雷伯菌中未发现。肺炎克雷伯菌中的所有sul1基因都存在于1类整合子中。基因盒阵列dfrA5和dfrA15-aadA1与1类整合子最常相关,而2类整合子仅包含dfrA1-sat2-aadA1基因盒。这是关于人源肺炎克雷伯菌中sul3基因的首次报道。大肠杆菌和肺炎克雷伯菌耐药机制不同这一发现可能会拓宽我们对复方新诺明耐药性的理解。